Unilever is looking to sell or de-emphasize its food & beverage units as it eyes the consumer healthcare division of GlaxoSmithKline, whose products include Advil pain reliever and Aquafresh and Sensodyne toothpaste.
The latest bid was reported at $68 billion, which would require Unilever to raise cash, which may prompt it to sell off its remaining food & beverage portfolio.
Unilever’s food & beverage products include Ben & Jerry’s ice cream and Hellman’s mayonnaise.
According to Unilever, its strategic direction lies in materially expanding its health, beauty, and hygiene businesses, which would require major acquisitions accompanied by the accelerated divestment of lower-growth brands and businesses.
Unilever had sold parts of its food and beverage businesses recently, including its spreads portfolio in 2017 and most of its tea business in 2020.
According to Unilever CEO Alan Jope, while its food and refreshments products are still profitable, its long-term growth profile has been below other parts of its portfolio.


U.S. Stock Futures Edge Higher Ahead of Big Tech Earnings and Fed Decision
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
U.S. and EU Strengthen Critical Minerals Partnership to Reduce China Dependence
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal
SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback
US Sanctions Target Iran’s Shadow Banking Network and Terror Financing
Asian Stocks Mixed as BOJ Holds Rates, Oil Prices and Fed Outlook Weigh on Markets
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case
Gold Prices Drop Amid Iran War Concerns, Rising Oil Costs, and Hawkish Central Bank Signals
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales 



